Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Cornberg

Showing results (81-90 of 350) with videos related to

Pageof 35
Sort By:
Clinical and Translational Gastroenterology|September 26, 2018
Association Between Type 2 Diabetes Mellitus, HbA1c and the Risk for Spontaneous Bacterial Peritonitis in Patients with Decompensated Liver Cirrhosis and AscitesTammo L Tergast, Hans Laser, Svetlana Gerbel, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|April 20, 2016
[Current seroprevalence, vaccination and predictive value of liver enzymes for hepatitis B among refugees in Germany]Annika Hampel, Philipp Solbach, Markus Cornberg, et al.
Zeitschrift Fur Gastroenterologie|November 11, 2022
Frank Tacke, Markus Cornberg, Martina Sterneck, et al.
Viral Immunology|February 6, 2014
How to interpret borderline HCV antibody test results: a comparative study investigating four different anti-HCV assaysBenjamin Maasoumy, Birgit Bremer, Regina Raupach, et al.
Zeitschrift Fur Gastroenterologie|April 12, 2021
Frank Tacke, Markus Cornberg, Martina Sterneck, et al.
Alimentary Pharmacology & Therapeutics|August 3, 2019
Systemic arterial blood pressure determines the therapeutic window of non-selective beta blockers in decompensated cirrhosisTammo L Tergast, Markus Kimmann, Hans Laser, et al.
European Journal of Gastroenterology & Hepatology|April 14, 2020
Liver stiffness across different chronic liver disease under therapy with statin in a real life cohortAntoaneta A Markova, Katja Deterding, Kerstin Port, et al.
Journal of Hepatology|November 28, 2017
Stomach reduction or gastric bypass as risk factor for treatment failure after DAA therapy for hepatitis C?Katharina L Hupa, Katja Deterding, Kerstin Port, et al.
JHEP Reports : Innovation in Hepatology|April 15, 2020
Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paperTobias Boettler, Philip N Newsome, Mario U Mondelli, et al.
The Journal of Infectious Diseases|September 30, 2016
Direct-Acting Antiviral-Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis CJulia Hengst, Christine Susanne Falk, Verena Schlaphoff, et al.
Pageof 35

Showing results (81-90 of 350) with videos related to

Sort By:
Pageof 35
Clinical and Translational Gastroenterology|September 26, 2018
Association Between Type 2 Diabetes Mellitus, HbA1c and the Risk for Spontaneous Bacterial Peritonitis in Patients with Decompensated Liver Cirrhosis and AscitesTammo L Tergast, Hans Laser, Svetlana Gerbel, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|April 20, 2016
[Current seroprevalence, vaccination and predictive value of liver enzymes for hepatitis B among refugees in Germany]Annika Hampel, Philipp Solbach, Markus Cornberg, et al.
Zeitschrift Fur Gastroenterologie|November 11, 2022
Frank Tacke, Markus Cornberg, Martina Sterneck, et al.
Viral Immunology|February 6, 2014
How to interpret borderline HCV antibody test results: a comparative study investigating four different anti-HCV assaysBenjamin Maasoumy, Birgit Bremer, Regina Raupach, et al.
Zeitschrift Fur Gastroenterologie|April 12, 2021
Frank Tacke, Markus Cornberg, Martina Sterneck, et al.
Alimentary Pharmacology & Therapeutics|August 3, 2019
Systemic arterial blood pressure determines the therapeutic window of non-selective beta blockers in decompensated cirrhosisTammo L Tergast, Markus Kimmann, Hans Laser, et al.
European Journal of Gastroenterology & Hepatology|April 14, 2020
Liver stiffness across different chronic liver disease under therapy with statin in a real life cohortAntoaneta A Markova, Katja Deterding, Kerstin Port, et al.
Journal of Hepatology|November 28, 2017
Stomach reduction or gastric bypass as risk factor for treatment failure after DAA therapy for hepatitis C?Katharina L Hupa, Katja Deterding, Kerstin Port, et al.
JHEP Reports : Innovation in Hepatology|April 15, 2020
Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paperTobias Boettler, Philip N Newsome, Mario U Mondelli, et al.
The Journal of Infectious Diseases|September 30, 2016
Direct-Acting Antiviral-Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis CJulia Hengst, Christine Susanne Falk, Verena Schlaphoff, et al.
Pageof 35